Form D · Pharmaceuticals
Topica Pharmaceuticals Inc
Los Altos, CA · CIK 0001533299
Offering snapshot reported Jun 10, 2013 · SEC filing
- Reported sold
- $31.5M Offering amount: $36.3M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 17, 2011 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$20,019,071 → $31,519,071
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 10, 2013 | Amendment | $31,519,071 | $11,500,000vs Oct 25, 2011 | 11 | SEC filing |
| Oct 25, 2011 | Initial | $20,019,071 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-167801
Sales and issuance of Series B Preferred Stock and the underlying Common Stock issuable upon conversion thereof
Source: Form D, filed Jun 10, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alex Barkas | Director |
| David Cohen, Md | Director |
| David E. Cohen Md Mph | Director |
| Catherine De Porceri Morton | Executive |
| Joseph Golemme | Executive |
| Russell Hirsch, Md, Ph.D. | Director |
| Charles Homcy Md | Director |
| Charles Homcy, Md | Director |
| Norifumi Nakamura | Executive |
| G. Kirk Raab | Director |
| Charles Gregory Vontz | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4300 El Camino Real Suite 101
Los Altos, CA, 94022
Los Altos, CA, 94022